{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:51:06Z","timestamp":1784346666717,"version":"3.55.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.bcp.2013.10.025","type":"journal-article","created":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T16:30:18Z","timestamp":1384187418000},"page":"399-409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Pharmacogenomics of cantharidin in tumor cells"],"prefix":"10.1016","volume":"87","author":[{"given":"Onat","family":"Kadioglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navid Salehi","family":"Kermani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Kelter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz-Herbert","family":"Fiebig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry Johannes","family":"Greten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Efferth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2013.10.025_bib0005","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2354.2006.00685.x","article-title":"Traditional Chinese medicine in cancer care: perspectives and experiences of patients and professionals in China","volume":"15","author":"Xu","year":"2006","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.bcp.2013.10.025_bib0010","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/np068054v","article-title":"Natural products as sources of new drugs over the last 25 years","volume":"70","author":"Newman","year":"2007","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bcp.2013.10.025_bib0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jep.2011.12.041","article-title":"Fighting fire with fire: poisonous Chinese herbal medicine for cancer therapy","volume":"140","author":"Wang","year":"2012","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.bcp.2013.10.025_bib0020","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1365-2044.2003.30523.x","article-title":"In defence of traditional Chinese herbal medicine","volume":"58","author":"Hosbach","year":"2003","journal-title":"Anaesthesia"},{"key":"10.1016\/j.bcp.2013.10.025_bib0025","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2174\/138920011798062328","article-title":"Toxicities by herbal medicines with emphasis to traditional Chinese medicine","volume":"12","author":"Efferth","year":"2011","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.bcp.2013.10.025_bib0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jep.2009.07.040","article-title":"Quality and safety of Chinese herbal medicines guided by a systems biology perspective","volume":"126","author":"Wang","year":"2009","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.bcp.2013.10.025_bib0035","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/01926230600773958","article-title":"Traditional toxicity documentation of Chinese Materia Medica \u2013 an overview","volume":"34","author":"Leung","year":"2006","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.bcp.2013.10.025_bib0040","series-title":"Pharmacopoeia of People's Republic of China","author":"State Pharmacopoeia Commission","year":"2010"},{"key":"10.1016\/j.bcp.2013.10.025_bib0045","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3928\/0090-4481-20050301-10","article-title":"How and when to treat molluscum contagiosum and warts in children","volume":"34","author":"Smolinski","year":"2005","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.bcp.2013.10.025_bib0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0378-8741(89)90062-7","article-title":"Medical uses of mylabris in ancient China and recent studies","volume":"26","author":"Wang","year":"1989","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.bcp.2013.10.025_bib0055","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1309\/BTFH-L0UH-P326-UB5D","article-title":"Positive and negative interference of the Chinese medicine Chan Su in serum digoxin measurement. Elimination of interference by using a monoclonal chemiluminescent digoxin assay or monitoring free digoxin concentration","volume":"114","author":"Dasgupta","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bcp.2013.10.025_bib0060","first-page":"398","article-title":"GC\/MS confirmation of cantharidin toxicosis due to ingestion of blister beetles","volume":"22","author":"Ray","year":"1980","journal-title":"Vet Hum Toxicol"},{"key":"10.1016\/j.bcp.2013.10.025_bib0065","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.toxicon.2011.10.002","article-title":"Possible cantharidin poisoning of a great bustard (Otis tarda)","volume":"59","author":"Sanchez-Barbudo","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2013.10.025_bib0070","first-page":"887","article-title":"Case report: Molluscum contagiosum. Toxic shock syndrome following cantharidin treatment","volume":"49","author":"Langley","year":"2003","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.bcp.2013.10.025_bib0075","doi-asserted-by":"crossref","first-page":"258","DOI":"10.18295\/2075-0528.1196","article-title":"Cantharidin poisoning due to blister beetle ingestion in children: two case reports and a review of clinical presentations","volume":"10","author":"Al-Binali","year":"2010","journal-title":"Sultan Qaboos Univ Med J"},{"key":"10.1016\/j.bcp.2013.10.025_bib0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/096032719000900108","article-title":"Post-mortem serum concentration of cantharidin in a fatal case of cantharides poisoning","volume":"9","author":"Hundt","year":"1990","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.bcp.2013.10.025_bib0085","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/archderm.137.10.1357","article-title":"Cantharidin revisited: a blistering defense of an ancient medicine","volume":"137","author":"Moed","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.bcp.2013.10.025_bib0090","unstructured":"Deutsches Arzneibuch DAB 6. Stuttgart: Deutscher Apotheker Verlag; 1926."},{"key":"10.1016\/j.bcp.2013.10.025_bib0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0014-5793(93)80889-3","article-title":"Cantharidin another natural toxin that inhibits the activity of serine\/threonine protein phosphatases types 1 and 2A","volume":"330","author":"Honkanen","year":"1993","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2013.10.025_bib0100","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.bcp.2004.12.003","article-title":"Molecular modes of action of cantharidin in tumor cells","volume":"69","author":"Efferth","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2013.10.025_bib0105","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1349-7006.2010.01523.x","article-title":"Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2\/M cell-cycle arrest and apoptosis","volume":"101","author":"Li","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.bcp.2013.10.025_bib0110","first-page":"1067","article-title":"Cantharidin induces G2\/M phase arrest and apoptosis in human colorectal cancer colo 205 cells through inhibition of CDK1 activity and caspase-dependent signaling pathways","volume":"38","author":"Huang","year":"2011","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bcp.2013.10.025_bib0115","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.bmcl.2007.03.093","article-title":"Heterocyclic substituted cantharidin and norcantharidin analogues \u2013 synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity","volume":"17","author":"Hill","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bcp.2013.10.025_bib0120","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2174\/1871520610909040392","article-title":"The effects of cantharidin and cantharidin derivates on tumour cells","volume":"9","author":"Liu","year":"2009","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.bcp.2013.10.025_bib0125","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.ejmech.2010.01.004","article-title":"Synthesis and biological activity of Delta-5,6-norcantharimides: importance of the 5,6-bridge","volume":"45","author":"Thaqi","year":"2010","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bcp.2013.10.025_bib0130","first-page":"4382","article-title":"Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells","volume":"48","author":"Fodstad","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2013.10.025_bib0135","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/jnci\/89.20.1505","article-title":"Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns","volume":"89","author":"Wosikowski","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bcp.2013.10.025_bib0140","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/jnci\/82.13.1113","article-title":"Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines","volume":"82","author":"Rubinstein","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bcp.2013.10.025_bib0145","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00001813-199508000-00005","article-title":"Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assays","volume":"6","author":"Dengler","year":"1995","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.bcp.2013.10.025_bib0150","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bcp.2013.10.025_bib0155","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature02582","article-title":"Structural basis of protein phosphatase 1 regulation","volume":"429","author":"Terrak","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2013.10.025_bib0160","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.molcel.2008.08.006","article-title":"Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation","volume":"31","author":"Xu","year":"2008","journal-title":"Molecular cell"},{"key":"10.1016\/j.bcp.2013.10.025_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1014460818734","article-title":"Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues","volume":"20","author":"Sakoff","year":"2002","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.bcp.2013.10.025_bib0170","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1749-8546-2-8","article-title":"Molecular biology of cantharidin in cancer cells","volume":"2","author":"Rauh","year":"2007","journal-title":"Chin Med"},{"key":"10.1016\/j.bcp.2013.10.025_bib0175","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1016\/j.fct.2008.06.084","article-title":"Liposome encapsulation reduces cantharidin toxicity","volume":"46","author":"Chang","year":"2008","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.bcp.2013.10.025_bib0180","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/j.1349-7006.2008.00872.x","article-title":"Cantharidin induces apoptosis of human multiple myeloma cells via inhibition of the JAK\/STAT pathway","volume":"99","author":"Sagawa","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.bcp.2013.10.025_bib0185","first-page":"1243","article-title":"Cantharidin induces apoptosis in human bladder cancer TSGH 8301 cells through mitochondria-dependent signal pathways","volume":"37","author":"Kuo","year":"2010","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bcp.2013.10.025_bib0190","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.canlet.2011.02.009","article-title":"PP2A inhibitors induce apoptosis in pancreatic cancer cell line PANC-1 through persistent phosphorylation of IKKalpha and sustained activation of the NF-kappaB pathway","volume":"304","author":"Li","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bcp.2013.10.025_bib0195","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1440-1711.2002.01068.x","article-title":"Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack","volume":"80","author":"Maher","year":"2002","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.bcp.2013.10.025_bib0200","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00018-011-0866-4","article-title":"CD95-mediated cell signaling in cancer: mutations and post-translational modulations","volume":"69","author":"Tauzin","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bcp.2013.10.025_bib0205","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s004419900160","article-title":"Apoptosis and cancer chemotherapy","volume":"301","author":"Makin","year":"2000","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.bcp.2013.10.025_bib0210","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3892\/or.2012.2118","article-title":"Norcantharidin suppresses cell growth and migration with enhanced anticancer activity of gefitinib and cisplatin in human non-small cell lung cancer cells","volume":"29","author":"Lee","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bcp.2013.10.025_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2005.02143.x","article-title":"The intriguing biology of the tumour necrosis factor\/tumour necrosis factor receptor superfamily: players, rules and the games","volume":"115","author":"Hehlgans","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.bcp.2013.10.025_bib0220","doi-asserted-by":"crossref","first-page":"e44956","DOI":"10.1371\/journal.pone.0044956","article-title":"Norcantharidin facilitates LPS-mediated immune responses by up-regulation of AKT\/NF-kappaB signaling in macrophages","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2013.10.025_bib0225","doi-asserted-by":"crossref","first-page":"190281","DOI":"10.1155\/2013\/190281","article-title":"Suppressions of migration and invasion by cantharidin in TSGH-8301 human bladder carcinoma cells through the inhibitions of matrix metalloproteinase-2\/-9 signaling","volume":"2013","author":"Huang","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.bcp.2013.10.025_bib0230","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s12272-013-0044-3","article-title":"Anti-metastatic effect of cantharidin in A549 human lung cancer cells","volume":"36","author":"Kim","year":"2013","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.bcp.2013.10.025_bib0235","doi-asserted-by":"crossref","DOI":"10.1515\/hsz-2013-0128","article-title":"Targeting caspases in cancer therapeutics","author":"Hensley","year":"2013","journal-title":"Biol Chem"},{"key":"10.1016\/j.bcp.2013.10.025_bib0240","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbrc.2007.05.090","article-title":"NM23-H2 involves in negative regulation of Diva and Bcl2L10 in apoptosis signaling","volume":"359","author":"Kang","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2013.10.025_bib0245","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/hmg\/10.21.2329","article-title":"Bcl2-L-10, a novel anti-apoptotic member of the Bcl-2 family, blocks apoptosis in the mitochondria death pathway but not in the death receptor pathway","volume":"10","author":"Zhang","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bcp.2013.10.025_bib0250","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1158\/1535-7163.MCT-07-0073","article-title":"Phytochemistry and pharmacogenomics of natural products derived from traditional Chinese medicine and Chinese Materia Medica with activity against tumor cells","volume":"7","author":"Efferth","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2013.10.025_bib0255","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cbi.2010.02.002","article-title":"Factors determining sensitivity or resistance of tumor cell lines towards artesunate","volume":"185","author":"Sertel","year":"2010","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bcp.2013.10.025_bib0260","doi-asserted-by":"crossref","first-page":"e35584","DOI":"10.1371\/journal.pone.0035584","article-title":"Factors determining sensitivity and resistance of tumor cells to arsenic trioxide","volume":"7","author":"Sertel","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2013.10.025_bib0265","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jsb.2003.11.027","article-title":"Levels of MCM4 phosphorylation and DNA synthesis in DNA replication block checkpoint control","volume":"146","author":"Ishimi","year":"2004","journal-title":"J Struct Biol"},{"key":"10.1016\/j.bcp.2013.10.025_bib0270","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1101\/gad.1541607","article-title":"Post-translational regulation of the Drosophila circadian clock requires protein phosphatase 1 (PP1)","volume":"21","author":"Fang","year":"2007","journal-title":"Genes Dev"},{"key":"10.1016\/j.bcp.2013.10.025_bib0275","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.bi.58.070189.002321","article-title":"The structure and regulation of protein phosphatases","volume":"58","author":"Cohen","year":"1989","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.bcp.2013.10.025_bib0280","doi-asserted-by":"crossref","first-page":"D1262","DOI":"10.2741\/A361","article-title":"Role of PP2A in intracellular signal transduction pathways","volume":"3","author":"Schonthal","year":"1998","journal-title":"Front Biosci"},{"key":"10.1016\/j.bcp.2013.10.025_bib0285","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1091\/mbc.4.4.397","article-title":"Dephosphorylation of cdc25-C by a type-2A protein phosphatase: specific regulation during the cell cycle in Xenopus egg extracts","volume":"4","author":"Clarke","year":"1993","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.bcp.2013.10.025_bib0290","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0968-0004(99)01375-4","article-title":"Regulation of protein kinase cascades by protein phosphatase 2A","volume":"24","author":"Millward","year":"1999","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.bcp.2013.10.025_bib0295","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1083\/jcb.128.6.1131","article-title":"A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle","volume":"128","author":"Sontag","year":"1995","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bcp.2013.10.025_bib0300","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.neo.7900213","article-title":"Microtubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1","volume":"3","author":"Pathan","year":"2001","journal-title":"Neoplasia"},{"key":"10.1016\/j.bcp.2013.10.025_bib0305","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1128\/MCB.19.12.8469","article-title":"BCL-2 is phosphorylated and inactivated by an ASK1\/Jun N-terminal protein kinase pathway normally activated at G(2)\/M","volume":"19","author":"Yamamoto","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2013.10.025_bib0310","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1073\/pnas.96.7.3775","article-title":"Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis","volume":"96","author":"Srivastava","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2013.10.025_bib0315","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1073\/pnas.92.10.4507","article-title":"Inactivation of Bcl-2 by phosphorylation","volume":"92","author":"Haldar","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2013.10.025_bib0320","first-page":"597","article-title":"Signal-induced site specific phosphorylation targets Bcl2 to the proteasome pathway","volume":"21","author":"Basu","year":"2002","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bcp.2013.10.025_bib0325","first-page":"459","article-title":"Microarray-based prediction of cytotoxicity of tumor cells to cantharidin","volume":"13","author":"Efferth","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bcp.2013.10.025_bib0330","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1006\/bcmd.2002.0492","article-title":"Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells","volume":"28","author":"Efferth","year":"2002","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.bcp.2013.10.025_bib0335","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/CAD.0b013e3282eeb1c5","article-title":"Anticancer activity and mechanisms of norcantharidin-Nd3II on hepatoma","volume":"18","author":"Yang","year":"2007","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.bcp.2013.10.025_bib0340","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/ijc.24157","article-title":"The effect of cantharidins on leukemic stem cells","volume":"124","author":"Dorn","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2013.10.025_bib0345","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/cas.12120","article-title":"Norcantharidin inhibits tumor angiogenesis via blocking VEGFR2\/MEK\/ERK signaling pathways","volume":"104","author":"Zhang","year":"2013","journal-title":"Cancer Sci"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295213007090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295213007090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T20:10:54Z","timestamp":1746043854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295213007090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0006295213007090"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2013.10.025","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacogenomics of cantharidin in tumor cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2013.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}